We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$35.2B
AUM Growth
+$2.25B
Cap. Flow
+$1.59B
Cap. Flow %
4.52%
Top 10 Hldgs %
5.35%
Holding
3,470
New
295
Increased
1,678
Reduced
1,270
Closed
203

Sector Composition

Rank Sector Weight
1 Financials 11.12%
2 Technology 11.03%
3 Industrials 10.67%
4 Consumer Discretionary 9.98%
5 Healthcare 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPLS
3201
CALL
DELISTED
Staples Inc
SPLS
$29K ﹤0.01%
+2,600
New +$34K
INSG icon
3202
Inseego
INSG
$86.3M
$28K ﹤0.01%
1,598
+363
+29% +$8.76K
SES
3203
DELISTED
Synthesis Energy Systems Inc.
SES
$28K ﹤0.01%
+227
New +$20.3K
REE
3204
DELISTED
RARE ELEMENT RES LTD
REE
$28K ﹤0.01%
19,364
+4,401
+29% +$7.12K
GEVO icon
3205
Gevo
GEVO
$351M
$27K ﹤0.01%
+4
New +$31.6K
LOCM
3206
DELISTED
LOCAL CORP COM STK (DE)
LOCM
$27K ﹤0.01%
13,928
+3,167
+29% +$5.31K
FLL icon
3207
Full House Resorts
FLL
$79.4M
$25K ﹤0.01%
+11,461
New +$28.4K
MEA
3208
DELISTED
METALICO INC
MEA
$25K ﹤0.01%
15,611
+3,544
+29% +$7.18K
PRXI
3209
DELISTED
PREMIER EXHIBITIONS INC COM STK NEW (FL)
PRXI
$25K ﹤0.01%
2,631
+598
+29% +$5.97K
GNK
3210
DELISTED
GENCO SHIPPING & TRADING LTD
GNK
$25K ﹤0.01%
+14,339
New +$27.4K
CASI
3211
DELISTED
CASI Pharmaceuticals
CASI
$24K ﹤0.01%
1,295
+294
+29% +$5.56K
NAVB
3212
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$24K ﹤0.01%
655
-71
-10% -$2.69K
DSS icon
3213
DSS Inc
DSS
$5.02M
$23K ﹤0.01%
8
+3
+60% +$11K
GNSS icon
3214
Genasys
GNSS
$80.2M
$23K ﹤0.01%
+10,765
New +$21.9K
SDEV
3215
Stablecoin Development Corp
SDEV
$52.5M
0
AMSC icon
3216
American Superconductor
AMSC
$1.59B
$22K ﹤0.01%
1,371
+47
+4% +$839
CDXS icon
3217
Codexis
CDXS
$159M
$22K ﹤0.01%
+10,764
New +$19.7K
GERN icon
3218
Geron
GERN
$1.01B
$22K ﹤0.01%
11,012
-2,181
-17% -$8.7K
EGIO
3219
DELISTED
Edgio, Inc. Common Stock
EGIO
$22K ﹤0.01%
253
-3
-1% -$254
MGN
3220
DELISTED
MINES MGMT INC
MGN
$22K ﹤0.01%
19,800
+4,502
+29% +$4.66K
FSGI
3221
DELISTED
FIRST SECURITY GROUP, INC.
FSGI
$22K ﹤0.01%
10,238
+14
+0.1% +$29
VGZ icon
3222
Vista Gold
VGZ
$296M
$21K ﹤0.01%
41,957
+9,528
+29% +$5.72K
THMO
3223
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$21K ﹤0.01%
+1
New +$17.5K
ACER
3224
DELISTED
Acer Therapeutics Inc
ACER
$21K ﹤0.01%
+135
New +$20.5K
APP
3225
DELISTED
AMERICAN APPAREL INC COM
APP
$21K ﹤0.01%
42,038
+6,500
+18% +$5.9K

Similar funds

Guggenheim Capital's Q1 2014 Portfolio in Review

As of Q1 2014, Guggenheim Capital held 3,470 positions worth $35.2B, up 6.8% from $32.9B the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

Guggenheim Capital deployed $1.59B of net new capital in Q1 2014, opening 295 new positions and adding to 1,678 existing holdings. Its largest new stake was Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust: 1,154,388 shares worth $23.9M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 12% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, an estimated $39M trimmed.

  • Guggenheim Capital's largest Q1 2014 buy was Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust: 1,154,388 shares worth $23.9M.
  • Guggenheim Capital added most to State Street SPDR S&P 500 ETF Trust in Q1 2014, an estimated $86.8M increase.
  • Guggenheim Capital's biggest Q1 2014 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $39M.
  • Guggenheim Capital fully exited GUGGENGEIM BULLETSHARES 2014 HIGH YIELD CORPORATE BOND ETF in Q1 2014, selling an estimated $65.1M.
  • Guggenheim Capital's ten largest holdings make up 5.3% of its $35.2B portfolio in Q1 2014.
  • Guggenheim Capital opened 295 new positions and closed 203 in Q1 2014.
  • Guggenheim Capital's portfolio value rose 6.8% quarter-over-quarter to $35.2B.

Based on Guggenheim Capital's 13F filing for Q1 2014, filed 16 May 2014.